Extreme hypofractionated stereotactic radiotherapy for elderly prostate cancer patients: side effects preliminary analysis of a phase II trial.
Gregucci F, Carbonara R, Surgo A, Ciliberti MP, Curci D, Ciocia A, Branà L, Ludovico GM, Scarcia M, Portoghese F, Caliandro M, Ludovico E, Paulicelli E, Di Guglielmo FC, Bonaparte I, Fiorentino A.
Gregucci F, et al. Among authors: portoghese f.
Radiol Med. 2023 Apr;128(4):501-508. doi: 10.1007/s11547-023-01618-5. Epub 2023 Mar 23.
Radiol Med. 2023.
PMID: 36952115
Clinical Trial.